期刊文献+

基于尿苷二磷酸葡萄糖醛酸转移酶的抑制性药物相互作用的体外定量预测

Quantitative prediction of UGT-based inhibitory drug-drug interactions from in vitro information
下载PDF
导出
摘要 尿苷二磷酸葡萄糖醛酸基转移酶(UDP-glucuronosyl-transferase,UGT)是一个结合酶超家族,催化了多种药物。已有许多与葡萄糖苷酸化相关的抑制性药物相互作用研究。体外实验方法和定量策略已经成功运用于体内葡萄糖醛酸化清除率以及抑制性药物相互作用的预测。该综述从这一领域相关基础知识和预测方法以及实验影响因素进行概述。 UDP-glucuronosyltransferase(UGT) is a family of conjugating enzymes that participate in the metabolism of many drugs.Inhibitory interactions involving glucuronidation have been described in a number of studies.Additionally,in vitro experimental approaches and scaling strategies have been successfully applied to the quantitative prediction of in vivo clearance via glucuronidation and inhibitory drug-drug interaction potential.In this overview,the methods,predictive models and newest advancement in this field have been summarized.
出处 《中国药理学通报》 CAS CSCD 北大核心 2011年第12期1644-1647,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 30901834 30801421) 国家科技重大新药创制科技专项(No 2009ZX09501-032)
关键词 尿苷二磷酸葡萄糖醛酸基转移酶 抑制 药物相互作用 体外体内外推法 肝脏清除率 底物 抑制剂 UDP-glucuronosyltransferase inhibition drug-drug interactions IV-IVE CLH substrates inhibitors
  • 相关文献

参考文献12

  • 1Bowalgaha K, Elliot D J, Mackenzie P I, et al. The glucuronida- tion of Delta(4)-3-keto C19- and C21-hydroxysteroids by human liver microsomal and recombinant UDP-glucuronosyltransferases (UGTs) : 6 alpha- and 21-hydroxyprogesterone are selective sub- strates for UGT2B7 [ J ]. Drug Metab Disposition, 2007, 35 ( 3 ) : 363 - 70.
  • 2Sahai J, Gallicano K, Pakuts A, Cameron D W. Effect of flucon- azole on zidovudine pharmacokinetics in patients infected with hu- man-immunodeficiency virus [ J ]. J Infect Dis, 1994, 169 ( 5 ) : 1103 -7.
  • 3Miners J O, Bowalgaha K, Elliot D J, et al. Characterization of ni- flumic acid as a selective inhibitor of human liver microsomal UDP- glucuronosyltransferase 1A9: application to the reaction phenoty- ping of acetaminophen glucuronidation [ J ]. Drug Metab Disposi- tion, 2011, 39(4) : 644 -52.
  • 4邓颖,陈杰,毕惠嫦,黄民.原代肝细胞培养及其在药物代谢和毒理学研究中的应用进展[J].中国药理学通报,2006,22(8):900-903. 被引量:29
  • 5张江虹,郝福荣,金问森,胡卓汉,金一尊.人肝微粒体CYP亚型在新型吲哚醌类化合物629代谢中的作用[J].中国药理学通报,2009,25(9):1167-1172. 被引量:2
  • 6Uchaipichat V, Mackenzie P I, Elliot D J, Miners J O. Selectivity of substrate (trifluoperazine) and inhibitor ( amitriptyline, andros- terone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human UDP- glucuro- nosyltransferases [ J ]. Drug Metab Disposition, 2006, 34 ( 3 ) : 449 -56.
  • 7Uchaipichat V, Winner L K, Mackenzie P I, et al. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation [ J ]. Br J Clin Pharmacol, 2006, 61 ( 4 ) : 427 - 39.
  • 8Rowland A, Knights K M, Mackenzie P I, Miners J O. The "Al- bumin Effect" and drug glucuronidation: Bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronida- tion of UDP-glucuronosyhransferase (UGT) 1A9 substrates but not UGT1 A1 and UGT1A6 activities [J]. Drug Metab Disposition, 2008, 36(6) : 1056 -62.
  • 9Rowland A, Elliot D J, Knights K M, et al. The "albumin effect" and in vitro-in vivo extrapolation: Sequestration of long-chain un- saturated fatty acids enhances phenytoin hydroxylation by human liver microsomal and recombinant cytochrome P4502C9 [ J]. Drug.
  • 10Wang Y, Kato N, Hoshida Y, et al UDP-glucuronosyhransferase 1A7 genetic polymorphisms are associated with hepatocellular car- cinoma in Japanese patients with hepatitis C virus infection [ J ]. Clin Cancer Res,2004, 10(7) : 2441 -6.

二级参考文献28

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部